308 related articles for article (PubMed ID: 35116924)
1. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
[TBL] [Abstract][Full Text] [Related]
2. Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer.
Ji Y; Qiu Q; Fu J; Cui K; Chen X; Xing L; Sun X
Cancer Manag Res; 2021; 13():307-317. PubMed ID: 33469373
[TBL] [Abstract][Full Text] [Related]
3. Machine learning based on clinico-biological features integrated
Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
[TBL] [Abstract][Full Text] [Related]
4. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
[TBL] [Abstract][Full Text] [Related]
5. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
[TBL] [Abstract][Full Text] [Related]
6. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
7. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
Front Oncol; 2021; 11():603882. PubMed ID: 33738250
[TBL] [Abstract][Full Text] [Related]
8. Predictive Power of a Radiomic Signature Based on
Li X; Yin G; Zhang Y; Dai D; Liu J; Chen P; Zhu L; Ma W; Xu W
Front Oncol; 2019; 9():1062. PubMed ID: 31681597
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtype classification of breast cancer using established radiomic signature models based on
Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
[No Abstract] [Full Text] [Related]
10. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer.
Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X
Front Oncol; 2021; 11():769272. PubMed ID: 34868999
[TBL] [Abstract][Full Text] [Related]
11. Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes.
Ma Y; Feng W; Wu Z; Liu M; Zhang F; Liang Z; Cui C; Huang J; Li X; Guo X
Phys Med Biol; 2018 Aug; 63(16):165018. PubMed ID: 30051884
[TBL] [Abstract][Full Text] [Related]
12. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
Zhang Y; Liu H; Chang C; Yin Y; Wang R
PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung.
Chen Z; Yi L; Peng Z; Zhou J; Zhang Z; Tao Y; Lin Z; He A; Jin M; Zuo M
Front Oncol; 2022; 12():949111. PubMed ID: 36505773
[TBL] [Abstract][Full Text] [Related]
14. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
15. Value of
Hu Y; Zhao X; Zhang J; Han J; Dai M
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):231-240. PubMed ID: 32588088
[TBL] [Abstract][Full Text] [Related]
16. The Machine Learning Model for Distinguishing Pathological Subtypes of Non-Small Cell Lung Cancer.
Zhao H; Su Y; Wang M; Lyu Z; Xu P; Jiao Y; Zhang L; Han W; Tian L; Fu P
Front Oncol; 2022; 12():875761. PubMed ID: 35692759
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a
Ouyang ML; Wang YR; Deng QS; Zhu YF; Zhao ZH; Wang L; Wang LX; Tang K
Front Oncol; 2021; 11():710909. PubMed ID: 34568038
[TBL] [Abstract][Full Text] [Related]
18. Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
Yang M; Shi L; Huang T; Li G; Shao H; Shen Y; Zhu J; Ni B
J Thorac Dis; 2023 Feb; 15(2):635-648. PubMed ID: 36910079
[TBL] [Abstract][Full Text] [Related]
19. Value of Presurgical
Dai M; Wang N; Zhao X; Zhang J; Zhang Z; Zhang J; Wang J; Hu Y; Liu Y; Zhao X; Chen X
Cancer Biother Radiopharm; 2022 Nov; ():. PubMed ID: 36342812
[No Abstract] [Full Text] [Related]
20. Value of [
Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]